This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Krog GR, Donneborg ML, Hansen BM, et al. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer. Pediatr Res 2021;90:74–81. doi: 10.1038/s41390-020-01232-5KrogGRDonneborgMLHansenBMPrediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.2021;90:74–81. doi:10.1038/s41390-020-01232-5Open DOISearch in Google Scholar
Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children. PLoS One 2020;15:7. doi: 10.1371/journal.pone.0235807PegoraroVUrbinatiDVisserGHAHemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children.2020;15:7. doi:10.1371/journal.pone.0235807Open DOISearch in Google Scholar
Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th ed. Hoboken, NJ: Wiley-Blackwell Publishing, 2005.KleinHGAnsteeDJ.11th ed.Hoboken, NJ:Wiley-Blackwell Publishing,2005.Search in Google Scholar
Bennardello F, Coluzzi S, Curciarello G, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) and Italian Society of Gynaecology and Obstetrics (SIGO) working group: recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn. Blood Transfus 2015;13:109–34. doi: 10.2450/2014.0119-14BennardelloFColuzziSCurciarelloGItalian Society of Transfusion Medicine and Immunohaematology (SIMTI) and Italian Society of Gynaecology and Obstetrics (SIGO) working group: recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.2015;13:109–34. doi:10.2450/2014.0119-14Open DOISearch in Google Scholar
Harmening DM. Modern blood banking and transfusion practices. 5th ed. Philadelphia, PA: F.A. Davis Company, 2005: 392.HarmeningDM.5th ed.Philadelphia, PA:F.A. Davis Company,2005:392.Search in Google Scholar
Bel Hadj I, Boukhris R, Khalsi F, et al. ABO hemolytic disease of newborn: does newborn’s blood group a risk factor? Tunis Med 2019;97:455–60.Bel HadjIBoukhrisRKhalsiFABO hemolytic disease of newborn: does newborn’s blood group a risk factor?2019;97:455–60.Search in Google Scholar
Adewuyi JO, Gwanzura C. Racial difference between White and Black Zimbabweans in the haemolytic activity of A, B, O antibodies. Afr J Med Med Sci 2001;30:71–4.AdewuyiJOGwanzuraC.Racial difference between White and Black Zimbabweans in the haemolytic activity of A, B, O antibodies.2001;30:71–4.Search in Google Scholar
Mourant AE, Kopéc AC, Domaniewska-Sobczak K. The distribution of the human blood groups and other biochemical polymorphisms. 2nd ed. Oxford: Oxford University Press, 1976.MourantAEKopécACDomaniewska-SobczakK..2nd ed.Oxford:Oxford University Press,1976.Search in Google Scholar
Badet J, Ropars C, Cartron JP, et al. Groups of alpha-D-galactosyltransferase activity in sera of individuals with normal B phenotype. II. Relationship between transferase activity and red cell agglutinability. Vox Sang 1976;30:105. doi: 10.1111/j.1423-0410.1976.tb02800.xBadetJRoparsCCartronJPGroups of alpha-D-galactosyltransferase activity in sera of individuals with normal B phenotype. II.1976;30:105. doi:10.1111/j.1423-0410.1976.tb02800.xOpen DOISearch in Google Scholar
Zonneveld R, van der Meer-Kapelle L, Sylva M, et al. Severe fetal hemolysis and cholestasis due to high-titer maternal IgG anti-A antibodies. Pediatrics 2019;143:e20182859. doi: 10.1542/peds.2018-2859ZonneveldRvan der Meer-KapelleLSylvaMSevere fetal hemolysis and cholestasis due to high-titer maternal IgG anti-A antibodies.2019;143:e20182859. doi:10.1542/peds.2018-2859Open DOISearch in Google Scholar
Grundbacher FJ. Genetics of anti-A and anti-B levels. Transfusion 1976;16:48–55. doi: 10.1046/j.1537-2995.1976. 16176130837.xGrundbacherFJGenetics of anti-A and anti-B levels.1976;16:48–55. doi:10.1046/j.1537-2995.1976. 16176130837.xOpen DOISearch in Google Scholar
Redman M, Malde R, Contreras M, et al. Comparison of IgM and IgG anti-A and anti-B levels in Asian, Caucasian and Negro donors in the north-west Thames region. Vox Sang 1990;59:89–91. doi: 10.1111/j.1423-0410.1990.tb05016.xRedmanMMaldeRContrerasMComparison of IgM and IgG anti-A and anti-B levels in Asian, Caucasian and Negro donors in the north-west Thames region.1990;59:89–91. doi:10.1111/j.1423-0410.1990.tb05016.xOpen DOISearch in Google Scholar
American Academy of Pediatrics Subcommittee on Hyper-bilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316. doi: 10.1542/peds.114.1.297American Academy of Pediatrics Subcommittee on Hyper-bilirubinemia.Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.2004;114:297–316. doi:10.1542/peds.114.1.297Open DOISearch in Google Scholar
Rahmati A, Farhat AS, Boroumand-Noughabi S, Soleymani F, Keramati M. Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years. Transfus Apher Sci 2022;61:103358. doi: 10.1016/j.transci.2022.103358RahmatiAFarhatASBoroumand-NoughabiSSoleymaniFKeramatiM.Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years.2022;61:103358. doi:10.1016/j.transci.2022.103358Open DOISearch in Google Scholar
Matteocci A, De Rosa A, Buffone E, et al. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years. Transfus Med 2019;29:197–201. doi: 10.1111/tme.12512MatteocciADe RosaABuffoneERetrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years.2019;29:197–201. doi:10.1111/tme.12512Open DOISearch in Google Scholar
Panda B. The incidence of the ABO hemolytic disease of the newborn and significance of various serological and laboratory investigations in its evaluation and diagnosis. Vox Sang 2021;116(S1):25–6.PandaB.The incidence of the ABO hemolytic disease of the newborn and significance of various serological and laboratory investigations in its evaluation and diagnosis.2021;116(S1):25–6.Search in Google Scholar
Siyah Bilgin B, Altun Koroglu O, Yalaz M, Karaman S, Kultursay N. Factors affecting bilirubin levels during first 48 hours of life in healthy infants. Biomed Res Int 2013;2013:316430. doi: 10.1155/2013/316430Siyah BilginBAltun KorogluOYalazMKaramanSKultursayN.Factors affecting bilirubin levels during first 48 hours of life in healthy infants.2013;2013:316430. doi:10.1155/2013/316430Open DOISearch in Google Scholar
El-Kabbany ZA, Toaima NN, Toaima TN, Gamal El-Din MY. Does anaesthesia in mothers during delivery affect bilirubin levels in their neonates? Korean J Pediatr 2017;60:385–9. doi: 10.3345/kjp.2017.60.12.385El-KabbanyZAToaimaNNToaimaTNGamal El-DinMY.Does anaesthesia in mothers during delivery affect bilirubin levels in their neonates?2017;60:385–9. doi:10.3345/kjp.2017.60.12.385Open DOISearch in Google Scholar
Akgül S, Korkmaz A, Yigit S, Yurdakök M. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter? Turk J Pediatr 2013;55:506–9AkgülSKorkmazAYigitSYurdakökM.Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?2013;55:506–9Search in Google Scholar
Bhat YR, Kumar CG. Morbidity of ABO haemolytic disease in the newborn. Paediatr Int Child Health 2012;32:93–6. doi: 10.1179/2046905512Y.0000000002BhatYRKumarCG.Morbidity of ABO haemolytic disease in the newborn.2012;32:93–6. doi:10.1179/2046905512Y.0000000002Open DOISearch in Google Scholar
Bujandric N, Grujic J. Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years’ experience from Vojvodina, Serbia. Indian J Hematol Blood Transfus 2016;32:208–14. doi: 10.1007/s12288-015-0534-1BujandricNGrujicJ.Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years’ experience from Vojvodina, Serbia.2016;32:208–14. doi:10.1007/s12288-015-0534-1Open DOISearch in Google Scholar
Strauss RG. Hemolytic disease of the fetus/newborn: reflections on articles from Transfusion Volume 1. Transfusion 2010;50:748–51. doi: 10.1111/j.1537-2995.2009.02453.xStraussRG.Hemolytic disease of the fetus/newborn: reflections on articles from Transfusion Volume 1.2010;50:748–51. doi:10.1111/j.1537-2995.2009.02453.xOpen DOISearch in Google Scholar
Basu S, Kaur R, Kaur G. Hemolytic disease of the fetus and newborn: current trends and perspectives. Asian J Transfus Sci 2011;5:3–7. doi: 10.4103/0973-6247.75963BasuSKaurRKaurG.Hemolytic disease of the fetus and newborn: current trends and perspectives.2011;5:3–7. doi:10.4103/0973-6247.75963Open DOISearch in Google Scholar
Kemper AR, Newman TB, Slaughter JL, et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2022;150:e2022058859.KemperARNewmanTBSlaughterJLClinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.2022;150:e2022058859.Search in Google Scholar